AI assistant
NeuroPace Inc — Director's Dealing 2021
Apr 20, 2021
33194_dirs_2021-04-20_d4b42748-e764-4cbf-aace-e9e724c7c8a6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2021-04-20
Reporting Person: Favet Michael (Director, Chief Executive Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 15385 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $0.03 | 2030-10-29 | Common Stock (976923) | Direct | |
| Stock Option (Right to Buy) | $0.03 | 2019-07-22 | Common Stock (35583) | Direct | |
| Series A' Preferred Stock | $0.00 | Common Stock (343) | Indirect | ||
| Series B' Preferred Stock | $0.00 | Common Stock (7219) | Indirect |
Footnotes
F1: Shares are held by the Favet Living Trust, of which the Reporting Person and the Reporting Person's spouse serve as co-trustees.
F2: 1/48th of the shares subject to the option vest in equal monthly installments commencing September 19, 2020.
F3: 25% of the shares subject to the option vest on August 1, 2020. 1/48th of the total shares subject to the option vest in 36 equal monthly installments thereafter.
F4: Each share of Preferred Stock automatically converts on a 1-for-1 basis into Common Stock at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date.